Axogen Files 8-K for Regulation FD Disclosure on Jan 5, 2024

Ticker: AXGN · Form: 8-K · Filed: Jan 8, 2024 · CIK: 805928

Axogen, Inc. 8-K Filing Summary
FieldDetail
CompanyAxogen, Inc. (AXGN)
Form Type8-K
Filed DateJan 8, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: regulatory-filing, compliance, 8-K

TL;DR

**Axogen just filed a routine 8-K, signaling standard regulatory compliance.**

AI Summary

Axogen, Inc. filed an 8-K on January 5, 2024, to report a current event, specifically a Regulation FD Disclosure and Financial Statements and Exhibits. This filing indicates that Axogen, Inc. is maintaining its compliance with SEC regulations, confirming its status as a publicly traded company on The Nasdaq Stock Market under the trading symbol AXGN. For investors, this matters because it signals ongoing regulatory adherence and transparency, which are crucial for maintaining investor confidence and market stability.

Why It Matters

This filing confirms Axogen's ongoing compliance with SEC reporting requirements, which is fundamental for investor trust and market transparency. It assures investors that the company is adhering to its obligations as a publicly traded entity.

Risk Assessment

Risk Level: low — This 8-K filing is routine and indicates compliance with regulatory requirements, posing no immediate new risks.

Analyst Insight

A smart investor would view this as a routine compliance filing, confirming Axogen's adherence to regulatory standards, and would continue to monitor for more substantive news regarding financial performance or strategic developments.

Key Numbers

  • 001-36046 — Commission File Number (identifies Axogen's registration with the SEC)
  • 41-1301878 — I.R.S. Employer Identification No. (Axogen's tax identification number)
  • 32615 — Zip Code (part of Axogen's principal executive offices address)
  • (386) 462-6800 — Registrant's telephone number (contact number for Axogen, Inc.)

Key Players & Entities

  • Axogen, Inc. (company) — the registrant filing the 8-K
  • The Nasdaq Stock Market (company) — the exchange where Axogen's common stock is registered
  • AXGN (company) — trading symbol for Axogen, Inc.
  • January 5, 2024 (date) — date of earliest event reported in the 8-K
  • $0.01 (dollar_amount) — par value of Axogen's Common Stock

FAQ

What is the primary purpose of Axogen, Inc.'s 8-K filing dated January 5, 2024?

The primary purpose of Axogen, Inc.'s 8-K filing dated January 5, 2024, is to report a current event under Regulation FD Disclosure and to include Financial Statements and Exhibits, as indicated by the 'ITEM INFORMATION' sections.

On which stock exchange is Axogen, Inc.'s Common Stock registered, and what is its trading symbol?

Axogen, Inc.'s Common Stock, with a $0.01 par value, is registered on The Nasdaq Stock Market under the trading symbol AXGN, as stated in the 'Securities registered pursuant to Section 12(b) of the Act' section.

What is the state of incorporation for Axogen, Inc.?

Axogen, Inc. is incorporated in Minnesota, as specified under 'State or Other Jurisdiction of Incorporation or Organization' in the filing.

What is the business address of Axogen, Inc. as listed in the filing?

The business address of Axogen, Inc. is 13631 Progress Boulevard, Suite 400, Alachua, Florida 32615, according to the 'Address of principal executive offices' section.

Does this 8-K filing indicate that Axogen, Inc. is an emerging growth company?

The filing includes a checkbox 'Indicate by check mark whether the registrant is an emerging growth company...' which is not checked, implying that Axogen, Inc. does not identify as an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Filing Stats: 514 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-01-08 07:05:00

Key Financial Figures

  • $0.01 — ange on which registered Common Stock, $0.01 par value AXGN The Nasdaq Stock Market

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 5, 2024, the Company posted an updated corporate presentation to its website at https://ir.axogeninc.com/news-events. The Company may use the investor presentation from time to time in conversation with analysts, investors and others. A copy of the investor update is furnished as Exhibit 99.1. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference into any filing under the Securities Act or Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits (d) Exhibits See the Exhibit index below, which is incorporated herein by reference. Exhibit No. Description 99.1 Axogen, Inc. Corporate Presentation, dated January 5, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AXOGEN, INC. Dated: January 8, 2024 By: Marc Began Marc Began Executive Vice President, General Counsel and Chief Compliance Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.